|
|
|
|
| LEADER |
04530nma a2201237 u 4500 |
| 001 |
EB001972712 |
| 003 |
EBX01000000000000001135614 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
210512 ||| eng |
| 020 |
|
|
|a 9783039214426
|
| 020 |
|
|
|a books978-3-03921-442-6
|
| 020 |
|
|
|a 9783039214419
|
| 100 |
1 |
|
|a Santos, Sílvio
|
| 245 |
0 |
0 |
|a Biotechnological Applications of Phage and Phage-Derived Proteins
|h Elektronische Ressource
|
| 260 |
|
|
|b MDPI - Multidisciplinary Digital Publishing Institute
|c 2019
|
| 300 |
|
|
|a 1 electronic resource (236 p.)
|
| 653 |
|
|
|a culture enrichment
|
| 653 |
|
|
|a Shigella flexneri
|
| 653 |
|
|
|a toxicity
|
| 653 |
|
|
|a Pseudomonas aeruginosa
|
| 653 |
|
|
|a microtiter plate assay
|
| 653 |
|
|
|a landscape phage
|
| 653 |
|
|
|a gene expression regulation
|
| 653 |
|
|
|a serotyping
|
| 653 |
|
|
|a nanotubular structures
|
| 653 |
|
|
|a fluorescence sensor
|
| 653 |
|
|
|a M13 bacteriophage
|
| 653 |
|
|
|a immune response
|
| 653 |
|
|
|a bacteriophage evolution
|
| 653 |
|
|
|a bacteriophage
|
| 653 |
|
|
|a n/a
|
| 653 |
|
|
|a receptor-binding protein
|
| 653 |
|
|
|a Streptococcus agalactiae
|
| 653 |
|
|
|a safety
|
| 653 |
|
|
|a reporter phage
|
| 653 |
|
|
|a nanomedicine
|
| 653 |
|
|
|a ESKAPE
|
| 653 |
|
|
|a tailspike proteins
|
| 653 |
|
|
|a diagnostics
|
| 653 |
|
|
|a biosensors
|
| 653 |
|
|
|a History of engineering and technology / bicssc
|
| 653 |
|
|
|a native gel electrophoresis
|
| 653 |
|
|
|a drug delivery vehicles
|
| 653 |
|
|
|a Pal
|
| 653 |
|
|
|a self-assembly
|
| 653 |
|
|
|a phage
|
| 653 |
|
|
|a pathogenic viruses
|
| 653 |
|
|
|a niosomes
|
| 653 |
|
|
|a alpha-sheet
|
| 653 |
|
|
|a sarcoidosis
|
| 653 |
|
|
|a phage therapy
|
| 653 |
|
|
|a molecular probe
|
| 653 |
|
|
|a Staphylococcus aureus
|
| 653 |
|
|
|a porous structure
|
| 653 |
|
|
|a Myoviridae
|
| 653 |
|
|
|a bacteriophages
|
| 653 |
|
|
|a O-antigen
|
| 653 |
|
|
|a Cpl-1
|
| 653 |
|
|
|a phage-host interaction
|
| 653 |
|
|
|a enzybiotics
|
| 653 |
|
|
|a biofilm
|
| 653 |
|
|
|a tail sheath protein
|
| 653 |
|
|
|a filters
|
| 653 |
|
|
|a macromolecular interactions
|
| 653 |
|
|
|a R-type pyocin
|
| 653 |
|
|
|a Enterococcus faecalis
|
| 653 |
|
|
|a bacteriophage vB_EcoM_FV3
|
| 653 |
|
|
|a in vitro activity
|
| 653 |
|
|
|a Clostridium perfringens
|
| 653 |
|
|
|a antibiotic resistance
|
| 653 |
|
|
|a cancerous tumors
|
| 653 |
|
|
|a tuberculosis
|
| 653 |
|
|
|a microarray
|
| 653 |
|
|
|a neurodegenerative disease
|
| 653 |
|
|
|a Streptococcus pneumoniae
|
| 653 |
|
|
|a Appelmans
|
| 653 |
|
|
|a encapsulation
|
| 653 |
|
|
|a capsid dynamics
|
| 653 |
|
|
|a endolysin
|
| 653 |
|
|
|a immunoscreening
|
| 653 |
|
|
|a bacteriocin
|
| 653 |
|
|
|a phage display
|
| 653 |
|
|
|a liposomes
|
| 653 |
|
|
|a transfersomes
|
| 653 |
|
|
|a major coat protein
|
| 653 |
|
|
|a contractile injection systems
|
| 653 |
|
|
|a bacteriophage recombination
|
| 653 |
|
|
|a T7phage library
|
| 653 |
|
|
|a X-ray crystallography
|
| 653 |
|
|
|a Listeria monocytogenes
|
| 653 |
|
|
|a magnetic separation
|
| 653 |
|
|
|a bacteriophage-derived lytic enzyme
|
| 700 |
1 |
|
|a Azeredo, Joana
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b DOAB
|a Directory of Open Access Books
|
| 500 |
|
|
|a Creative Commons (cc), https://creativecommons.org/licenses/by-nc-nd/4.0/
|
| 028 |
5 |
0 |
|a 10.3390/books978-3-03921-442-6
|
| 856 |
4 |
2 |
|u https://directory.doabooks.org/handle/20.500.12854/42299
|z DOAB: description of the publication
|
| 856 |
4 |
0 |
|u https://www.mdpi.com/books/pdfview/book/1633
|7 0
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 900
|
| 082 |
0 |
|
|a 610
|
| 082 |
0 |
|
|a 576
|
| 082 |
0 |
|
|a 600
|
| 082 |
0 |
|
|a 620
|
| 520 |
|
|
|a Phages have shown a high biotechnological potential with numerous applications. The advent of high-resolution microscopy techniques aligned with omic and molecular tools have revealed innovative phage features and enabled new processes that can be further exploited for biotechnological applications in a wide variety of fields. The high-quality original articles and reviews presented in this Special Issue demonstrate the incredible potential of phages and their derived proteins in a wide range of biotechnological applications for human benefit. Considering the emergence of amazing new available bioengineering tools and the high abundance of phages and the multitude of phage proteins yet to be discovered and studied, we believe that the upcoming years will present us with many more fascinating and new previously unimagined phage-based biotechnological applications.
|